| Literature DB >> 28904288 |
Kyoko Hataoka1, Asuka Kaizaki-Mitsumoto1, Satoshi Numazawa1.
Abstract
A synthetic cathinone, 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (α-PVP), was occasionally found in the "bath salt" type of designer drugs, as an active ingredient. It has been reported that drivers who consumed α-PVP were in an excited state and incapable of controlling their behavior, causing traffic accidents. Despite its acute excitatory effects, there is no information on the psychological dependency elicited by α-PVP use. The purpose of the present study was to clarify whether the reward pathway is activated with repeated doses of α-PVP in experimental animals. Treatment of male C57BL/6j mice with α-PVP (25 mg/kg, i.p.), once a day, for 3 days significantly increased the conditioned place preference scores. Therefore, repeated doses of α-PVP were shown to induce palatability in mice. α-PVP increases extracellular dopamine levels in the nucleus accumbens shell immediately after administration. The number of cells immunopositive for phosphorylated cAMP-regulatory element binding protein (CREB) was significantly increased in the α-PVP-treated mice in our study. These results indicate that the administration of α-PVP activates the phosphorylation of CREB in the nucleus accumbens shell. Our results suggest that α-PVP stimulates the reward pathway by increasing the extracellular dopamine levels and CREB phosphorylation in the nucleus accumbens shell, eventually causing positive reinforcement in mice.Entities:
Keywords: 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (α-PVP); CREB; Conditioned place preference; Immunohistochemistry; Microdialysis
Mesh:
Substances:
Year: 2017 PMID: 28904288 DOI: 10.2131/jts.42.539
Source DB: PubMed Journal: J Toxicol Sci ISSN: 0388-1350 Impact factor: 2.196